TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
22 hedge funds and large institutions have $5.76M invested in Talis Biomedical Corporation Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$80K |
| 2 |
2
Renaissance Technologies
New York
|
$21K |
| 3 |
3
Morgan Stanley
New York
|
$29.8K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$82 |
